2016
DOI: 10.3233/jad-160522
|View full text |Cite
|
Sign up to set email alerts
|

So Close Yet So Far: Executive Contribution to Memory Processing in Behavioral Variant Frontotemporal Dementia

Abstract: Background: Memory impairment in behavioral variant frontotemporal dementia (bvFTD) is traditionally considered to be mild and attributed to prefrontal cortex dysfunction. Recent studies, however, indicated that some patients can present with a memory impairment of the hippocampal type, showing storage and consolidation deficits in addition to the more executive/prefrontal related encoding and strategic difficulties.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
13
1
1

Year Published

2017
2017
2024
2024

Publication Types

Select...
8

Relationship

4
4

Authors

Journals

citations
Cited by 20 publications
(15 citation statements)
references
References 49 publications
0
13
1
1
Order By: Relevance
“…In addition, to overcome the limitation of the memory test applied in this study, the use of more sensitive neuropsychological tests and specific to temporal lobe impairment will help to refine our results and better describe the extent and nature of impairments in ALS. Importantly, to evaluate executive dysfunction impact on memory performance, specific assessments are recommended, similarly to what has been performed in bvFTD (Bertoux et al, 2016).…”
Section: Discussionmentioning
confidence: 99%
“…In addition, to overcome the limitation of the memory test applied in this study, the use of more sensitive neuropsychological tests and specific to temporal lobe impairment will help to refine our results and better describe the extent and nature of impairments in ALS. Importantly, to evaluate executive dysfunction impact on memory performance, specific assessments are recommended, similarly to what has been performed in bvFTD (Bertoux et al, 2016).…”
Section: Discussionmentioning
confidence: 99%
“…bvFTD on its part has been characterized by a remarkable change in personality with prominent apathy and disinhibition, accompanied by a lack of empathy and insight, stereotypical behaviors and changes in eating habits (e.g., the development of a 'sweet tooth'), obsessive-compulsive behaviors, yet with relative preservation of other cognitive areas such as visuospatial function and memory in the early stages [12,29]. However, a subset of patients with bvFTD exhibit early problems with episodic memory [17], which in some occasions can easily be confused with AD, because they show the same type of memory loss. The diagnostic criteria currently used are those proposed by Raskovsky et al, which even though do not consider the memory impairment in bvFTD, have demonstrated to be more sensitive than previous criteria [30].…”
Section: Clinical Profiles Of Ad and Bvftdmentioning
confidence: 99%
“…For instance, there are consistent differences between clinical findings in early onset AD (EOAD) and late-onset AD (LOAD), where the onset of EOAD is more likely to be marked by atypical symptoms, and cognitive assessments point to poorer executive, visuospatial functioning and praxis, with less marked memory impairment [16]. Turning to bvFTD, there is significant evidence that demonstrates that some bvFTD patients show memory impairment similar to AD in episodic memory tests, which is in line with a hippocampal affectation profile [17,18]. Therefore, the diagnosis of YOD continues to be a challenge despite considerable improvement in the quality of neuropsychology, neuroimaging and biomarker assays [5,10].…”
Section: Introductionmentioning
confidence: 98%
“…We presented a series of three case reports with patients initially demonstrating a clinical phenotype of ASHT suggestive of typical amnesic AD, which was related to different pathologies: FTD, PSP, and typical AD. In the FTD case, the low free recall probably resulted from a frontal-related retrieval deficit, whereas the poor efficacy of the cueing was presumably related to hippocampal involvement known to occur in FTD [15,31], and evidenced by HA on MRI. The normality of pathophysiological CSF biomarkers excluded the diagnosis of AD, and symptom evolution confirmed bvFTD.…”
Section: Discussionmentioning
confidence: 92%